S.E.F.H on Twitter: "❗️❗️❗️Especial atención a las posibles interacciones por Paxlovid (PF-07321332/ritonavir) Info detallada en ficha técnica: https://t.co/QbXlibCBu6" / Twitter
Development of Caco-2 cells-based gene reporter assays and evaluation of herb-drug interactions involving CYP3A4 and CYP2D6 gene expression - ScienceDirect
PDF) Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential Problems
CYP3A4 - Wikipedia
Pharmacokinetic drug‐drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy - Gay - 2017 - Hematological Oncology - Wiley Online Library
7 Molecular structures involved in pharmacodynamics and... | Download Table
Induction of human CYP3A4 by huperzine A, ligustrazine and oridonin through pregnane X receptor-mediated pathways
CYP3A4 - Wikipedia
JCM | Free Full-Text | Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders | HTML
The Role of Cytochrome P450 3A Inducers and Inhibitors in the Metabolism and the Effects of Oxycodone | Semantic Scholar
Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia - ScienceDirect
Drug Interactions with CYP3A4: An Update
inductores potentes del CYP3A4: Evite fuertes inductores de CYP3A4
Effects of Standardized Medicinal Plant Extracts on Drug Metabolism Mediated by CYP3A4 and CYP2D6 Enzymes | Chemical Research in Toxicology
The Role of Cytochrome P450 3A Inducers and Inhibitors in the Metabolism and the Effects of Oxycodone | Semantic Scholar
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen | Pharmacogenomics
Enzyme induction with antiepileptic drugs: Cause for concern? - Brodie - 2013 - Epilepsia - Wiley Online Library
Genómica y prescripción de psicofármacos - ppt descargar
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen | Pharmacogenomics